These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23719288)

  • 1. Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design.
    Tanaka T; Sugawara H; Maruoka H; Imajo S; Muto T
    Bioorg Med Chem; 2013 Jul; 21(14):4233-49. PubMed ID: 23719288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors.
    Maruoka H; Muto T; Tanaka T; Imajo S; Tomimori Y; Fukuda Y; Nakatsuka T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3435-9. PubMed ID: 17434735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitors.
    Tanaka T; Muto T; Maruoka H; Imajo S; Fukami H; Tomimori Y; Fukuda Y; Nakatsuka T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3431-4. PubMed ID: 17419055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational studies of novel chymase inhibitors against cardiovascular and allergic diseases: mechanism and inhibition.
    Arooj M; Thangapandian S; John S; Hwang S; Park JK; Lee KW
    Chem Biol Drug Des; 2012 Dec; 80(6):862-75. PubMed ID: 22834787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors.
    Futamura-Takahashi J; Tanaka T; Sugawara H; Iwashita S; Imajo S; Oyama Y; Muto T
    Bioorg Med Chem Lett; 2018 Jan; 28(2):188-192. PubMed ID: 29191554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent, selective chymase inhibitors via fragment linking strategies.
    Taylor SJ; Padyana AK; Abeywardane A; Liang S; Hao MH; De Lombaert S; Proudfoot J; Farmer BS; Li X; Collins B; Martin L; Albaugh DR; Hill-Drzewi M; Pullen SS; Takahashi H
    J Med Chem; 2013 Jun; 56(11):4465-81. PubMed ID: 23659209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole RSK inhibitors. Part 1: discovery and initial SAR.
    Boyer SJ; Burke J; Guo X; Kirrane TM; Snow RJ; Zhang Y; Sarko C; Soleymanzadeh L; Swinamer A; Westbrook J; Dicapua F; Padyana A; Cogan D; Gao A; Xiong Z; Madwed JB; Kashem M; Kugler S; O'Neill MM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):733-7. PubMed ID: 22100312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
    Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L
    Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel broad-spectrum inhibitors of bacterial methionine aminopeptidase.
    Rose JA; Lahiri SD; McKinney DC; Albert R; Morningstar ML; Shapiro AB; Fisher SL; Fleming PR
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3301-6. PubMed ID: 26099541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of isoindoline-1,3-diones and 2,3-dihydrophthalazine-1,4-diones as novel B-Raf inhibitors.
    Wang X; Salaski EJ; Berger DM; Powell D; Hu Y; Wojciechowicz D; Collins K; Frommer E
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6941-4. PubMed ID: 22024030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
    Vicker N; Sharland CM; Heaton WB; Gonzalez AM; Bailey HV; Smith A; Springall JS; Day JM; Tutill HJ; Reed MJ; Purohit A; Potter BV
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):259-65. PubMed ID: 18775469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.
    Griebenow N; Buchmueller A; Kolkhof P; Schamberger J; Bischoff H
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3648-53. PubMed ID: 21576018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors.
    Murafuji H; Sakai H; Goto M; Imajo S; Sugawara H; Muto T
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5272-5276. PubMed ID: 29102227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors.
    Neelamkavil SF; Boyle CD; Chackalamannil S; Greenlee WJ; Zhang L; Terracina G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4563-5. PubMed ID: 19625185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
    Murafuji H; Sakai H; Goto M; Oyama Y; Imajo S; Sugawara H; Tomoo T; Muto T
    Bioorg Med Chem Lett; 2018 May; 28(8):1371-1375. PubMed ID: 29550094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of thienobenzoxepin inhibitors of PI3-kinase.
    Staben ST; Siu M; Goldsmith R; Olivero AG; Do S; Burdick DJ; Heffron TP; Dotson J; Sutherlin DP; Zhu BY; Tsui V; Le H; Lee L; Lesnick J; Lewis C; Murray JM; Nonomiya J; Pang J; Prior WW; Salphati L; Rouge L; Sampath D; Sideris S; Wiesmann C; Wu P
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4054-8. PubMed ID: 21636270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
    Sund C; Belda O; Borkakoti N; Lindberg J; Derbyshire D; Vrang L; Hamelink E; Åhgren C; Woestenenk E; Wikström K; Eneroth A; Lindström E; Kalayanov G
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6721-7. PubMed ID: 23010268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease.
    Li H; Qin J; Dhondi P; Zhou W; Vicarel M; Bara T; Cole D; Josien H; Pissarnitski D; Zhu Z; Palani A; Aslanian R; Clader J; Czarniecki M; Greenlee W; Cohen-Williams M; Hyde L; Song L; Zhang L; Chu I; Huang X
    Bioorg Med Chem Lett; 2013 Jan; 23(2):466-71. PubMed ID: 23253441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazepane-acetamide derivatives as selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
    Odermatt A
    Expert Opin Ther Pat; 2009 Oct; 19(10):1477-83. PubMed ID: 19780703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PF-04859989 as a template for structure-based drug design: identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency.
    Dounay AB; Anderson M; Bechle BM; Evrard E; Gan X; Kim JY; McAllister LA; Pandit J; Rong S; Salafia MA; Tuttle JB; Zawadzke LE; Verhoest PR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):1961-6. PubMed ID: 23466229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.